Clinical Laserthermia Systems AB (publ) (STO:CLS.B)
Sweden · Delayed Price · Currency is SEK 11.00
-0.82 (-6.94%)
Sep 5, 2025, 5:29 PM CET
STO:CLS.B Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 23.88 | 18.78 | 8.27 | 6.27 | 2.25 | 1.33 | Upgrade |
Other Revenue | -0 | -0 | 0 | - | - | - | Upgrade |
| 23.88 | 18.78 | 8.27 | 6.27 | 2.25 | 1.33 | Upgrade | |
Revenue Growth (YoY) | 57.14% | 127.03% | 31.99% | 179.20% | 68.54% | -75.79% | Upgrade |
Cost of Revenue | 6.21 | 8.36 | 5.28 | 9.06 | 5.88 | 0.46 | Upgrade |
Gross Profit | 17.67 | 10.42 | 3 | -2.79 | -3.63 | 0.88 | Upgrade |
Selling, General & Admin | 50.18 | 62.04 | 66.13 | 62.29 | 54.2 | 49.77 | Upgrade |
Other Operating Expenses | -0.2 | -0.06 | -0.36 | -0.09 | -0 | 0.01 | Upgrade |
Operating Expenses | 52.65 | 64.65 | 68.48 | 64.65 | 56.98 | 52.83 | Upgrade |
Operating Income | -34.98 | -54.23 | -65.48 | -67.44 | -60.61 | -51.96 | Upgrade |
Interest Expense | -0.4 | -0.43 | -9.76 | -10.97 | -6.41 | -3.27 | Upgrade |
Interest & Investment Income | 3.1 | 6.83 | 0.3 | 7.4 | 2.91 | - | Upgrade |
Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.45 | -0 | -0.07 | -0.29 | Upgrade |
Other Non Operating Income (Expenses) | -0.25 | -0 | -0 | -0.22 | 0.03 | 0.19 | Upgrade |
EBT Excluding Unusual Items | -32.56 | -47.86 | -75.39 | -71.24 | -64.14 | -55.33 | Upgrade |
Gain (Loss) on Sale of Investments | -10.72 | - | -5.48 | -0.03 | - | -2.61 | Upgrade |
Pretax Income | -43.27 | -47.86 | -80.88 | -71.27 | -64.14 | -57.94 | Upgrade |
Earnings From Continuing Operations | -43.27 | -47.86 | -80.88 | -71.27 | -64.14 | -57.94 | Upgrade |
Minority Interest in Earnings | 0.07 | 0.24 | 1.08 | 0.61 | 0.53 | - | Upgrade |
Net Income | -43.21 | -47.62 | -79.79 | -70.66 | -63.62 | -57.94 | Upgrade |
Net Income to Common | -43.21 | -47.62 | -79.79 | -70.66 | -63.62 | -57.94 | Upgrade |
Shares Outstanding (Basic) | 19 | 11 | 3 | 0 | 0 | 0 | Upgrade |
Shares Outstanding (Diluted) | 19 | 11 | 3 | 0 | 0 | 0 | Upgrade |
Shares Change (YoY) | 181.65% | 227.83% | 705.35% | 45.02% | 30.24% | 27.46% | Upgrade |
EPS (Basic) | -2.28 | -4.32 | -23.76 | -169.43 | -221.20 | -262.38 | Upgrade |
EPS (Diluted) | -2.28 | -4.32 | -23.76 | -169.43 | -221.20 | -262.38 | Upgrade |
Free Cash Flow | -48.74 | -63.93 | -68.6 | -82.1 | -66.32 | -55.76 | Upgrade |
Free Cash Flow Per Share | -2.57 | -5.81 | -20.42 | -196.85 | -230.61 | -252.49 | Upgrade |
Gross Margin | 73.99% | 55.47% | 36.23% | -44.51% | -161.69% | 65.77% | Upgrade |
Operating Margin | -146.50% | -288.72% | -791.47% | -1075.95% | -2699.97% | -3900.75% | Upgrade |
Profit Margin | -180.95% | -253.54% | -964.46% | -1127.31% | -2833.63% | -4349.78% | Upgrade |
Free Cash Flow Margin | -204.11% | -340.34% | -829.16% | -1309.76% | -2954.16% | -4185.81% | Upgrade |
EBITDA | -34.68 | -53.93 | -65.14 | -67.05 | -59.93 | -51.27 | Upgrade |
EBITDA Margin | -145.22% | -287.10% | - | - | - | - | Upgrade |
D&A For EBITDA | 0.3 | 0.3 | 0.34 | 0.39 | 0.68 | 0.69 | Upgrade |
EBIT | -34.98 | -54.23 | -65.48 | -67.44 | -60.61 | -51.96 | Upgrade |
EBIT Margin | -146.50% | -288.72% | - | - | - | - | Upgrade |
Revenue as Reported | - | - | - | - | 2.41 | 2.55 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.